Related Experiment Video

Updated: Jun 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation

L Miao1, Z Song, L Jin

  • 1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.

Oncogene
|November 11, 2009
PubMed

Insights

Myc-interacting zinc-finger protein-1 (Miz-1) suppresses p53 activity by inhibiting its DNA binding. Human alternate reading frame (ARF) protein counteracts this suppression by binding Miz-1, revealing Miz-1 as a novel mediator in the ARF-p53 pathway.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Protein Interactions

Background:

  • Myc-interacting zinc-finger protein-1 (Miz-1) is a POZ transcription factor known for repressing Myc.
  • The broader regulatory functions of Miz-1 beyond Myc repression are not fully understood.
  • The p53 tumor suppressor pathway is crucial for cellular responses to stress and DNA damage.

Purpose of the Study:

  • To identify novel interaction partners of Miz-1.
  • To elucidate the role of Miz-1 in regulating p53 transcriptional activity.
  • To investigate the interplay between Miz-1, ARF, and p53.

Main Methods:

  • Yeast two-hybrid screening to identify Miz-1 interacting proteins.
  • In vitro binding assays to confirm protein-protein interactions.
  • Competitive chromatin immunoprecipitation (ChIP) assays to assess promoter binding in cells.

Main Results:

  • Human alternate reading frame (ARF) protein was identified as a novel binding partner of Miz-1.
  • Miz-1 binds to p53 via its DNA-binding domain, inhibiting p53's ability to bind target promoters and suppress transcription.
  • ARF and p53 competitively bind to Miz-1, with ARF counteracting Miz-1-mediated p53 suppression.

Conclusions:

  • Miz-1 acts as a suppressor of p53 transcriptional activity by interfering with p53 DNA binding.
  • ARF antagonizes Miz-1's suppression of p53 through direct interaction with Miz-1.
  • Miz-1 is a novel mediator in the ARF-p53 pathway, highlighting a new regulatory mechanism in cancer biology.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...